Other Income & Expense

Sale of Subsidiary Stock

Accenture Sale of Subsidiary Stock decreased by 2.3% to $466.20M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $477.37M to $466.20M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Positive proceeds indicate successful monetization of assets, while the absence of such activity suggests a focus on retaining control of existing subsidiaries.

Detailed definition

This captures the cash proceeds or financial impact resulting from the sale of equity interests in a subsidiary. It refl...

Peer comparison

Often reported under 'Proceeds from sale of investments' or 'Divestitures' in the investing section.

Metric ID: is_wmt_sale_of_subsidiary_stock

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$409.13M$465.71M$477.43M$477.37M$466.20M
QoQ Change+13.8%+2.5%-0.0%-2.3%
YoY Change+13.8%+2.5%-0.0%-2.3%
Range$409.13M$477.43M
CAGR+13.9%
Avg YoY Growth+3.5%
Median YoY Growth+1.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Accenture's sale of subsidiary stock?
Accenture (ACN) reported sale of subsidiary stock of $466.20M in Q4 2025.
How has Accenture's sale of subsidiary stock changed year-over-year?
Accenture's sale of subsidiary stock decreased by 2.3% year-over-year, from $477.37M to $466.20M.
What does sale of subsidiary stock mean?
Cash generated from selling shares of a subsidiary company.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.